According to a new market report published by Lucintel, the future of the glycomics market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics market is expected to grow with a CAGR of 14% from 2020 to 2025. The major drivers for this market are increasing research and development activities related to drug discovery, rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools, and growing proteomics market.
To download report brochure, please go to https://www.lucintel.com/glycomics-market.aspx and click "download brochure" tab from the menu
Glycomics refers to the study of glycomes, including physiologic, genetic, pathologic, and other aspects. Glycomics is a subset of glycobiology that studies systematically about all glycan structures of a given cell type or organism. In this market, drug discovery & development, disease diagnostics are the major applications. Lucintel forecasts that drug discovery and development will remain the largest segment over the forecast period due to increasing research and development activities related to glycomics and proteomics.
Within this market, academic and research institutes will remain the largest segment by end user over the forecast period due to increasing research and development activities and growing adoption of glycan structure data analysis by research centers.
North America will remain the largest region over the forecast period due to government fundings for research and development activities and presence of advanced healthcare infrastructure in the region.
Merck, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Takara Bio, S-BIO, Waters Corporation, Asparia Glycomics, and Bio-Techne are among the major suppliers in the global glycomics market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global glycomics market by product, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Glycomics Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global glycomics market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Enzymes
Glycosidases & Neuramidases
Glycosyltransferases & Sialyltransferases
Other Enzymes
Instruments
Mass Spectrometry Instruments
Chromatography Instruments
Arrays
Other Instruments
Carbohydrates
Oligosaccharides
Monosaccharides
Other Carbohydrates
Reagents & Chemicals
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Drug Discovery & Development
Disease Diagnostics
Cancer Diagnostics
Other Disease Diagnostics
Other Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Clinical Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This more than 150-pages research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.